TU
CRL icon

TDAM USA’s Charles River Laboratories CRL Stock Holding History

TDAM USA’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.27M Sell
3,372
-101
-3% -$39.2K 0.08% 145
2021
Q3 		$1.43M Sell
3,473
-190
-5% -$78.9K 0.09% 137
2021
Q2 		$1.49M Sell
3,663
-27,494
-88% -$9.18M 0.09% 135
2021
Q1 		$9.03M Sell
31,157
-8,398
-21% -$2.33M 0.55% 56
2020
Q4 		$9.88M Sell
39,555
-688
-2% -$164K 0.62% 46
2020
Q3 		$9.11M Buy
40,243
+164
+0.4% +$34K 0.63% 45
2020
Q2 		$6.77M Buy
40,079
+827
+2% +$132K 0.49% 67
2020
Q1 		$4.95M Sell
39,252
-171
-0.4% -$25.6K 0.42% 76
2019
Q4 		$6.02M Sell
39,423
-665
-2% -$92.1K 0.39% 90
2019
Q3 		$5.31M Buy
40,088
+3,895
+11% +$522K 0.38% 94
2019
Q2 		$5.14M Buy
+36,193
New +$4.91M 0.36% 91
2019
Q1 		– Sell
-11,206
Closed -$1.27M – 255
2018
Q4 		$1.27M Buy
+11,206
New +$1.4M 0.09% 157

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TDAM USA's CRL Position: Q4 2021 in Review

TDAM USA reduced its Charles River Laboratories (CRL) stake by 2.9% in Q4 2021, selling an estimated $39.2K and leaving 3,372 shares worth $1.27M. The position accounts for 0.08% of the portfolio, ranked #145.

TDAM USA first reported a position in CRL in Q4 2018 and has held it in 12 quarters since. The position peaked at $9.88M in Q4 2020. 708 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • TDAM USA held 3,372 shares of Charles River Laboratories worth $1.27M as of Q4 2021.
  • TDAM USA sold 101 Charles River Laboratories shares in Q4 2021, an estimated $39.2K.
  • Charles River Laboratories made up 0.08% of TDAM USA's portfolio in Q4 2021, its #145 holding.
  • TDAM USA first reported a position in Charles River Laboratories in Q4 2018 and has held it in 12 quarters since.
  • TDAM USA's Charles River Laboratories position peaked at $9.88M in Q4 2020.
  • 708 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.